Venrock Adviser, LLC

Q2 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
33
Total value ($000)
$3,298,052
Net value change ($000)
+618,930 (23.1%)
New positions
4
Sold out positions
4
Turnover %
7.3%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
APGE 412,435 57.7%
ORKA 191,326 94.0%
SYRE 79,154 42.6%
ERAS 62,704 23.7%
JBIO 26,310 58.1%
ACHV 17,964 NEW
PARABILIS MEDICINES INC 17,106 NEW
DNTH 16,000 16.2%
SVRA 15,813 21.1%
ANL 14,714 66.2%
Top Reduces (Value $000, Stocks/ETFs)
KALV -130,331 -100.0%
ELVN -40,961 -60.5%
ENGN -32,493 -100.0%
CTMX -28,233 -60.2%
TENX -26,787 -100.0%
VRDN -16,098 -21.2%
COGT -13,428 -17.4%
SEPN -12,161 -100.0%
ORIC -7,948 -14.5%
SRZN -2,012 -10.9%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type